May 28, 2020
Formulation scientists can provide early stage formulations that manage risks, enable clear inferences from the results of in vivo studies, […]
READ MORE >
Sophisticated formulations in every stage of development from MOLECULE to FORMULATION to CLINICAL 
Our Technologies
EMULSOL
AMORSOL
NANOSOL
A wide array of pharmaceutical development capabilities for manufacturing and
analyzing drug product dosage forms. READ MORE >
FEATURED
Ascendia Joins the Fight Against COVID-19
Ascendia Pharmaceuticals is proud to announce that it is engaged in multiple collaborations to develop and prepare injectable, inhalation, and […]
READ MOREPARTNERING WITH ASCENDIA
Ascendia provides its partners rapid, comprehensive and cost-effective
solutions for their difficult formulation development projects. LEARN MORE >
ASCENDIA NEWSROOM
May 19, 2020
Pharmaceutical and biotech companies evaluating contract development and manufacturing organizations (CDMOs) for formulation development of poorly soluble drugs must focus […]
READ MORE >May 13, 2020
Ascendia Pharmaceuticals’ suite of three patented IP technologies – AmorSol, EmulSol, and NanoSol – is included in an annual special […]
READ MORE >